SEC Filing Update: #CUE Cue Biopharma, Inc. Common Stock : $23.98

Sector: Healthcare | YTD: 🔼+ 135.10% The SEC disclosed Today (21-AUG-2026) that Shao-Lee Lin has Newly bought 467,166 #CUE shares Ownership: 6.2% * Estimated Investment Value: $13.02M https://www.thinksabio.com/reports/isr/CUE Institutional ownership in #CUE has been steadily rising over the past 2 quarters in Shares: Q1 2026: 715.05K Q2 2026: 1.57M 📌 Institutional activity in the last 30 days for #CUE: • DRIEHAUS CAPITAL MANAGEMENT LLC – Newly bought 292,144 shares (14-AUG-2026) Shao-Lee Lin acquired 467,166 shares of CUE, establishing a 6.2% ownership stake in the healthcare company.